• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

USP40 去泛素化 HINT1 并稳定足细胞损伤中的 p53。

USP40 deubiquitinates HINT1 and stabilizes p53 in podocyte damage.

机构信息

Department of Pediatrics, Kyorin University School of Medicine, Mitaka, Tokyo, 181-8611, Japan.

Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Mitaka, Tokyo, 181-8611, Japan.

出版信息

Biochem Biophys Res Commun. 2022 Jul 23;614:198-206. doi: 10.1016/j.bbrc.2022.05.043. Epub 2022 May 14.

DOI:10.1016/j.bbrc.2022.05.043
PMID:35605301
Abstract

Podocyte damage is a major pathological lesion leading to focal segmental glomerulosclerosis (FSGS). Podocytes damaged by cellular stress undergo hypertrophy to compensate for podocytopenia. It is known that cyclin-dependent kinase inhibitors induced by p53 ensure podocytes hypertrophy; however, its precise mechanism remains to be further investigated. In this study, we found that ubiquitin specific protease 40 (USP40) is a novel regulator of p53. Although USP40 knockout mice established in the present study revealed no abnormal kidney phenotype, intermediate filament Nestin was upregulated in the glomeruli, and was bound to and colocalized with USP40. We also found that USP40 deubiquitinated histidine triad nucleotide-binding protein 1 (HINT1), an inducer of p53. Gene knockdown experiments of USP40 in cultured podocytes revealed the reduction of HINT1 and p53 protein expression. Finally, in glomerular podocytes of mouse FSGS, upregulation of HINT1 occurred in advance of the proteinuria, which was followed by upregulation of USP40, p53 and Nestin. In conclusion, USP40 bound to Nestin deubiquitinates HINT1, and in consequence upregulates p53. These results provide additional insight into the pathological mechanism of podocyte hypertrophy in FSGS.

摘要

足细胞损伤是导致局灶节段性肾小球硬化症(FSGS)的主要病理病变。受细胞应激损伤的足细胞发生肥大以代偿足细胞减少症。已知 p53 诱导的细胞周期蛋白依赖性激酶抑制剂可确保足细胞肥大;然而,其确切的机制仍有待进一步研究。在这项研究中,我们发现泛素特异性蛋白酶 40(USP40)是 p53 的一种新型调节因子。尽管本研究中建立的 USP40 敲除小鼠未显示出异常的肾脏表型,但中间丝巢蛋白在肾小球中上调,并与 USP40 结合并共定位。我们还发现 USP40 去泛素化组氨酸三联核苷酸结合蛋白 1(HINT1),HINT1 是 p53 的诱导剂。在培养的足细胞中进行 USP40 的基因敲低实验表明,HINT1 和 p53 蛋白表达减少。最后,在 FSGS 小鼠的肾小球足细胞中,HINT1 的上调先于蛋白尿,随后 USP40、p53 和巢蛋白上调。总之,USP40 与 Nestin 结合,去泛素化 HINT1,从而上调 p53。这些结果为 FSGS 中足细胞肥大的病理机制提供了更多的见解。

相似文献

1
USP40 deubiquitinates HINT1 and stabilizes p53 in podocyte damage.USP40 去泛素化 HINT1 并稳定足细胞损伤中的 p53。
Biochem Biophys Res Commun. 2022 Jul 23;614:198-206. doi: 10.1016/j.bbrc.2022.05.043. Epub 2022 May 14.
2
USP40 gene knockdown disrupts glomerular permeability in zebrafish.USP40 基因敲低破坏斑马鱼肾小球通透性。
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F702-F715. doi: 10.1152/ajprenal.00197.2016. Epub 2017 Feb 1.
3
Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.在细胞性/塌陷性局灶节段性肾小球硬化小鼠模型中,基因标记的足细胞谱系显示足细胞进行性减少伴壁层细胞增生。
Am J Pathol. 2009 May;174(5):1675-82. doi: 10.2353/ajpath.2009.080789. Epub 2009 Apr 9.
4
AMPK mediates regulation of glomerular volume and podocyte survival.AMPK 介导肾小球体积和足细胞存活的调节。
JCI Insight. 2021 Oct 8;6(19):e150004. doi: 10.1172/jci.insight.150004.
5
The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.足细胞和壁层上皮细胞表型转化在局灶节段性肾小球硬化中的方向和作用。
Am J Physiol Renal Physiol. 2014 Jan 1;306(1):F98-F104. doi: 10.1152/ajprenal.00228.2013. Epub 2013 Oct 23.
6
Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.阻断核糖体蛋白 S6 磷酸化可抑制足细胞肥大和局灶节段性肾小球硬化。
Kidney Int. 2022 Jul;102(1):121-135. doi: 10.1016/j.kint.2022.02.037. Epub 2022 Apr 25.
7
Proteome Analysis of Isolated Podocytes Reveals Stress Responses in Glomerular Sclerosis.孤立的足细胞的蛋白质组分析揭示了肾小球硬化中的应激反应。
J Am Soc Nephrol. 2020 Mar;31(3):544-559. doi: 10.1681/ASN.2019030312. Epub 2020 Feb 11.
8
Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.内皮细胞线粒体氧化应激决定节段性肾小球硬化症中足细胞的耗竭。
J Clin Invest. 2014 Apr;124(4):1608-21. doi: 10.1172/JCI71195. Epub 2014 Mar 3.
9
MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.MAD2B 介导的足细胞细胞周期再进入参与 FSGS 的发病机制。
Int J Biol Sci. 2021 Oct 22;17(15):4396-4408. doi: 10.7150/ijbs.62238. eCollection 2021.
10
Glomerulosclerosis Induced by Deficiency of Membrane-Associated Guanylate Kinase Inverted 2 in Kidney Podocytes.肾足细胞中膜相关鸟苷酸激酶倒置2缺乏诱导的肾小球硬化
J Am Soc Nephrol. 2017 Sep;28(9):2654-2669. doi: 10.1681/ASN.2016121356. Epub 2017 May 24.

引用本文的文献

1
Identification Exploring the Mechanism and Clinical Validation of Mitochondrial Dynamics-Related Genes in Membranous Nephropathy Based on Mendelian Randomization Study and Bioinformatics Analysis.基于孟德尔随机化研究和生物信息学分析探索膜性肾病中线粒体动力学相关基因的机制及临床验证
Biomedicines. 2025 Jun 17;13(6):1489. doi: 10.3390/biomedicines13061489.
2
Indole-3-Acetic Acid Protects Against Lipopolysaccharide-induced Endothelial Cell Dysfunction and Lung Injury through the Activation of USP40.吲哚-3-乙酸通过激活 USP40 保护脂多糖诱导的内皮细胞功能障碍和肺损伤。
Am J Respir Cell Mol Biol. 2024 Sep;71(3):307-317. doi: 10.1165/rcmb.2024-0159OC.
3
USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1.
USP40通过去泛素化和稳定Claudin1来促进肝癌细胞的增殖、迁移和干性。
Biol Direct. 2024 Feb 2;19(1):13. doi: 10.1186/s13062-024-00456-3.
4
The deubiquitinase USP40 preserves endothelial integrity by targeting the heat shock protein HSP90β.去泛素化酶 USP40 通过靶向热休克蛋白 HSP90β 来维持内皮细胞完整性。
Exp Mol Med. 2024 Feb;56(2):395-407. doi: 10.1038/s12276-024-01160-y. Epub 2024 Feb 2.
5
Recent Advances in Proteinuric Kidney Disease/Nephrotic Syndrome: Lessons from Knockout/Transgenic Mouse Models.蛋白尿性肾病/肾病综合征的最新进展:基因敲除/转基因小鼠模型的经验教训
Biomedicines. 2023 Jun 23;11(7):1803. doi: 10.3390/biomedicines11071803.